What is the Fischer Medical Ventures Ltd share price today?

The share price of NSE:FISCHER-EQ on 07 Sep 2026 (as of 10:59:18 IST) is ₹35.73.

What is the NSE:FISCHER-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:FISCHER-EQ 52 week high low range shows a high of ₹124.70 and a low of ₹31.05.

What is the Fischer Medical Ventures Ltd market cap?

As on 07 Sep 2026, Fischer Medical Ventures Ltd market cap is ₹2517.36 Cr.

What is the shareholding pattern of Fischer Medical Ventures Ltd Stock?

The shareholding pattern of Fischer Medical Ventures Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 62.15% Foreign Institutional Investors (FII): 5.48% Domestic Institutional Investors (DII): 1.35% Mutual Funds: 0% Retail & Others: 31.02% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Fischer Medical Ventures Ltd?

The Price-to-Earnings (PE) ratio of Fischer Medical Ventures Ltd is 84.41, and the Price-to-Book (PB) ratio is 18.64, as on 07 Sep 2026.

Fischer Medical Ventures Share Price

32.87-0.28 (-0.84%)

-71.07% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.84%

1 Week

-1.88%

1 Month

-13.82%

3 Month

-6.51%

6 Month

-11.09%

YTD

-21.02%

1 Year

-71.07%

5 Year

10 Year

Max

-60.86%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

32.50

31.05

High

35.94

38.50

42.37

42.78

124.70

About

Fischer Chemic Ltd is a certified supplier of APIs&intermediate Herbal Medicine Food Additives Cosmetics Raw Materials Laboratory Instrument&Chemicals PVC Modifier Aquaculture equipments etc. They have two manufacturing bases located in Read more

Trading

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

ADANIENTNSE

AEGISLOGNSE

PREMIERENENSE

CPPLUSNSE

REDINGTONNSE

HONASANSE

LLOYDSENTNSE

SGMARTNSE

MMTCNSE

EBGNGNSE

FISCHERNSE

LTP

1W Low

1W High

Market cap (₹)

2975+55 (1.88%)

2907

3020

4,05,995Cr

1486+104.8 (7.59%)

1346.60

1500.20

49,746Cr

919.9+20.9 (2.32%)

878.30

919.90

40,992Cr

3482.3-65.4 (-1.84%)

3321

3549.40

39,653Cr

392.05+3.9 (1.00%)

385

413.20

31,248Cr

473.6+4.3 (0.92%)

458.10

481.50

15,636Cr

70.49+3.53 (5.27%)

66.60

70.92

10,501Cr

730.4+32.75 (4.69%)

694.15

747.85

9,240Cr

59.79-0.01 (-0.02%)

59.64

60.99

9,032Cr

690.45+44.9 (6.96%)

633.20

711.25

8,010Cr

32.87-0.63 (-1.88%)

32.50

35.94

2,320Cr

Fischer Medical Ventures Share Price

32.87-0.28 (-0.84%)

-71.07% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year428%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-34%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-71%

Return on Equity

10 years2%

5 years2%

3 years2%

Last year1%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	428%
-	-	-	-34%
-	-	-	-71%
2%	2%	2%	1%

Peer Comparison

Symbol

ADANIENT

AEGISLOG

PREMIERENE

CPPLUS

REDINGTON

HONASA

LLOYDSENT

SGMART

MMTC

EBGNG

FISCHER

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
2,975	₹405995 Cr	54.53	-8.91	105.06	₹9339 Cr
1,486	₹49746 Cr	39.76	13.8	41.65	₹898 Cr
919.9	₹40992 Cr	24.62	10.2	45.28	₹1510 Cr
3,482.3	₹39653 Cr	83.08	12.07	45.29	₹368 Cr
392.05	₹31248 Cr	18.37	6.22	24.36	₹1490 Cr
473.6	₹15636 Cr	62.83	2.77	8.99	₹200 Cr
70.49	₹10501 Cr	93.52	0.38	0.91	₹283 Cr
730.4	₹9240 Cr	74.32	3.62	10.96	₹111 Cr
59.79	₹9032 Cr	20.19	0.69	3.01	₹387 Cr
690.45	₹8010 Cr	56.24	2.54	13.51	₹132 Cr
32.87	₹2320 Cr	77.78	0.06	0.48	₹31 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024
₹82 Cr	₹98 Cr	₹101 Cr	₹86 Cr	₹23 Cr	₹49 Cr	₹12 Cr	₹40 Cr	₹10 Cr	₹21 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹7 Cr	₹15 L	₹38 L	₹22 L	₹74 L	₹47 L
₹83 Cr	₹99 Cr	₹102 Cr	₹89 Cr	₹31 Cr	₹49 Cr	₹12 Cr	₹40 Cr	₹11 Cr	₹21 Cr
₹72 Cr	₹98 Cr	₹80 Cr	₹71 Cr	₹20 Cr	₹47 Cr	₹12 Cr	₹39 Cr	₹11 Cr	₹18 Cr
₹13 Cr	₹2 Cr	₹23 Cr	₹19 Cr	₹12 Cr	₹3 Cr	₹88 L	₹72 L	₹48 L	₹3 Cr
₹4 Cr	₹4 Cr	₹64 L	₹92 L	₹66 L	₹23 L	₹7 L	₹5 L	₹13 L	₹5 L
₹8 Cr	-₹2 Cr	₹21 Cr	₹17 Cr	₹10 Cr	₹2 Cr	₹25 L	₹38 L	₹8 L	₹3 Cr
₹4 Cr	-₹7 Cr	₹19 Cr	₹14 Cr	₹5 Cr	₹1 Cr	-₹17 L	₹46 L	-₹12 L	₹3 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023
—	—	—
₹64 Cr	₹54 Cr	₹17 L
₹30 Cr	₹87 L	₹0
₹244 Cr	₹27 Cr	-₹44 L
₹244 Cr	₹27 Cr	-₹44 L
₹338 Cr	₹81 Cr	-₹27 L
₹34 L	₹0	₹0
₹0	₹0	₹57 L
₹26 L	₹0	₹0
₹53,000	₹12 L	-₹11 L
₹17 Cr	₹1 Cr	₹0
₹9 L	₹0	₹0
₹17 Cr	₹1 Cr	₹47 L
—	—	—
₹21 Cr	₹2 Cr	₹1 L
₹20 Cr	₹2 Cr	₹3 L
₹60 Cr	₹0	₹0
₹80 L	₹90,000	₹0
₹102 Cr	₹4 Cr	₹5 L
₹457 Cr	₹86 Cr	₹25 L
₹60 Cr	₹0	₹57 L
—	—	—
₹27 Cr	₹16 Cr	₹0
₹3 Cr	₹1 Cr	₹0
₹24 Cr	₹15 Cr	₹0
₹1 Cr	₹0	₹0
₹11 Cr	₹1 Cr	₹0
₹11 Cr	₹1 Cr	₹0
₹22 Cr	₹0	₹0
₹34 Cr	₹0	₹0
₹92 Cr	₹16 Cr	₹0
—	—	—
₹9 Cr	₹4 Cr	₹0
₹76 Cr	₹23 Cr	₹17 L
₹251 Cr	₹38 Cr	₹4 L
₹3 Cr	₹45 L	₹0
₹26 Cr	₹5 Cr	₹4 L
₹365 Cr	₹70 Cr	₹25 L
₹263 Cr	₹67 Cr	₹20 L
₹457 Cr	₹86 Cr	₹25 L
₹48	₹15	-₹15
₹5	₹1	-₹2

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023
₹2 Cr	₹2 Cr	₹0
₹2 Cr	₹25 L	₹0
-₹90 Cr	-₹10 Cr	₹0
-₹86 Cr	-₹7 Cr	₹0
-₹87 Cr	-₹7 Cr	₹0
-₹125 Cr	-₹31 Cr	₹0
₹315 Cr	₹37 Cr	₹0
₹103 Cr	-₹2 Cr	₹0
₹95 L	₹4 L	₹0
₹50,000	₹3 Cr	₹0
₹104 Cr	₹95 L	₹0

Fundamental Ratios

Consolidated

Standalone

No results found

Fischer Medical Ventures Share Price

32.87-0.28 (-0.84%)

-71.07% past 1 Year

Shareholding summary

Promoters

62.15%

FII

5.48%

DII

1.35%

Others

31.02%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
62.15%	62.15%	61.80%	61.80%	61.80%	62.81%
5.48%	4.97%	4.85%	5.57%	5.55%	5.23%
1.35%	1.38%	1.36%	1.42%	1.42%	1.44%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
31.02%	31.50%	31.99%	31.21%	31.23%	30.52%

Bulk & block deals

Name

Anand Mohan

Mohammadzahidhussain

Ravindradadajijilte

Arunkumar

Suresh Sabanna Itkal

Omkar Ashok Shinde

Kantilal B Shah

Gajanan Enterprises

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
10 Apr 2023	Sell	1 L	₹79.80	1.26 K	Bulk	0.000182	BSE
27 Dec 2021	Purchase	93.20 K	₹93.20	1 K	Bulk	0.000144	BSE
27 Dec 2021	Sell	90.75 K	₹93.27	973	Bulk	0.00014	BSE
23 Aug 2021	Purchase	83.95 K	₹90.07	932	Bulk	0.000135	BSE
09 Mar 2018	Purchase	11.25 K	₹12.50	900	Bulk	0.00013	BSE
09 Mar 2018	Sell	12.56 K	₹12.56	1 K	Bulk	0.000144	BSE
09 Jan 2015	Purchase	77.18 K	₹2.68	28.80 K	Bulk	0.004158	BSE
09 Jan 2015	Sell	1.04 L	₹2.68	38.80 K	Bulk	0.005601	BSE

Insider trading & SAST

Client name

Shankar Varadharajan & Pacs

Shankar Varadharajan & Others

Shankar Varadharajan & Pacs

Shankar Varadharajan & Others

Shankar Varadharajan & Pacs

Fmv Holdings Pte Ltd

Shankar Varadharajan

Fmv Holdings Pte Ltd

Shankar Varadharajan

Fmv Holdings Pte Ltd

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
27 Aug 2026	Promoter	Acquisition	1.91	63.06	0	—	1.33 Cr	14 Aug 2026	Pref. Allotment	44,03,08,440	SAST	29(2)	—
27 Aug 2026	Promoter	Acquisition	0.07	63.08	0	—	4.54 L	17 Aug 2026	Pref. Allotment	44,07,62,650	SAST	29(2)	—
27 Aug 2026	Promoter	Acquisition	1	62.66	0	—	66.32 L	12 Aug 2026	Pref. Allotment	41,56,94,314	SAST	29(2)	—
27 Aug 2026	Promoter	Acquisition	1.66	63	0	—	1.13 Cr	13 Aug 2026	Pref. Allotment	42,69,72,531	SAST	29(2)	—
27 Aug 2026	Promoter	Acquisition	0.35	62.5	0	—	23 L	11 Aug 2026	Pref. Allotment	40,90,62,650	SAST	29(2)	—
18 Aug 2026	Promoter	Acquisition	0.065615	50.78	1.06 Cr	₹23.40	4.54 L	17 Aug 2026	Conversion of security	35,47,61,120	Insider Trading	—	Equity
17 Aug 2026	Promoter	Acquisition	0.866762	12.32	14.04 Cr	₹23.40	60 L	14 Aug 2026	Conversion of security	8,60,01,530	Insider Trading	—	Equity
17 Aug 2026	Promoter	Acquisition	1.059748	50.74	17.17 Cr	₹23.40	73.36 L	14 Aug 2026	Conversion of security	35,43,06,910	Insider Trading	—	Equity
17 Aug 2026	Promoter	Acquisition	0.893222	12.32	14.04 Cr	₹23.40	60 L	14 Aug 2026	Conversion of security	8,60,01,530	Insider Trading	—	Equity
17 Aug 2026	Promoter	Acquisition	1.092099	50.74	17.17 Cr	₹23.40	73.36 L	14 Aug 2026	Conversion of security	35,43,06,910	Insider Trading	—	Equity

Fischer Medical Ventures Share Price

32.87-0.28 (-0.84%)

-71.07% past 1 Year

Corporate Actions

Date

Type

Details

2026-09-22

Dividend

0.05

2025-09-22

Dividend

0.005

2025-09-22

Dividend

0.05

2025-09-12

Split

10:1

Company details

Registered office

Survey No. 480/2 A P Medtech Zone Nadupura Village Pedagantyadu Mandal Vijayawada Andhra Pradesh PIN: 530032 Tel No: 08655550209 Fax No: NULL Email: [email protected] Internet: www.fischermv.com

Registrars

17-20 Jaferbhoy Industrial Estate , 1st Floor,Makwana Road,Marol Naka,Mumbai 17-20 Jaferbhoy Industrial Estate , 1st Floor Makwana Road Marol Naka PIN: Tel No: 022-42270400 Fax No: 022-28503748 Email: [email protected] Internet: www.adroitcorporate.com

Management

Ravindran Govindan, Chairman & Managing Director

Svetlana Rao Raviwada, Whole Time Director

Khairy Jamaluddin Abu Bakar, Non Executive Independent Director

Jaya Ankur Singhania, Non Executive Independent Director

Balaji Gandla, Company Secretary & Compliance Officer

Details

BSE 524743

NSE FISCHER

ISIN INE771F01041

Fischer Medical Ventures Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Fischer Medical Ventures Share Price

Fischer Medical Ventures Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Fischer Medical Ventures Share Price

Fischer Medical Ventures Share Price

Oscillators

Moving averages

Fischer Medical Ventures Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Fischer Medical Ventures Share Price

Corporate Actions

Company details

Fischer Medical Ventures Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Fischer Medical Ventures Share Price

News

Fischer Medical Ventures expands Southeast Asia imaging footprint via new deployment initiative

Fischer Medical Ventures to hold analyst and investor meet on September 7

Fischer Medical Ventures subsidiary launches Clarion AI CT system in India

Fischer Medical Ventures gets CDSCO nod for Spincare wound care device

Fischer Medical Ventures informs about outcome of board meeting

Fischer Medical reports Profit after tax of Rs -8.98 Crores, in the March 2026 quarter

Fischer Medical Ventures informs about appointment of CS cum CO

Fischer Medical - Quaterly Results

Fischer Medical Ventures Q3 FY26 EBITDA Surges to Rs 21.60 Crores, Margin Expands to 21.34% YoY.

Fischer Medical Ventures Reports Q3 Net Profit of Rs 19.20 Crores, Revenue Rs 100 Crores YoY.

Fischer Medical Ventures Board Approves Restructuring of Malaysian Subsidiary Shareholding.

Fischer Medical reports Profit after tax of Rs -1.67 Crores, in the December 2025 quarter

Fischer Medical Ventures Restructures Pellucidcare Health Innovations Transfer to Subsidiary

Fischer Medical Ventures informs about reconstitution of committees

Fischer Medical Ventures informs about press release

Fischer Medical Ventures’ arm wins order worth Rs 9.29 crore

Fischer Medical Ventures informs about press release

Fischer Medical Ventures informs about audio recording of conference call

Fischer Medical Ventures informs about press release

Fischer Medical Ventures informs about press release

Fischer Medical Ventures Ltd Share Price Today

Fischer Medical Ventures Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator